Rhythm hits record high as drug reduces weight in rare type of obesity

ReutersJul 9, 2025 1:55 PM

View all comments（0）



Shares of Rhythm Pharmaceuticals RYTM.O jump 23.7% to record high of $80.7

Experimental drug bivamelagon showed reductions in body mass index at 14 weeks of treatment in patients with acquired hypothalamic obesity

Tested the drug in a mid-stage trial of 28 patients aged 12 years or older

Plans to seek input from U.S. and EU regulatory authorities on a late-stage trial design

Acquired hypothalamic obesity is a rare form of obesity that occurs following damage to the hypothalamic region of the brain

Including session's move, stock up ~44% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Kospi Plunges Over 5% After Nearing 8,000 Points as South Korean Top Official Proposes ‘AI Profit Redistribution’

Tradingkey - During the early trading session on May 12, the KOSPI Index briefly touched the 8,000-point mark at the open before plunging more than 5% to a low of 7,421.71 points. As of press time, the index remains down 1.24% at 7,725.33 points. Samsung Electronics and SK Hynix, which together account for nearly half of the KOSPI's total market capitalization, were the primary drivers of this flash crash. Currently, SK Hynix is down 3.62% at 1.144 million KRW, while Samsung Electronics has fallen 2.28% to 279,000 KRW.

Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End

TradingKey - Despite the ongoing US-Iran war and the continued closure of the Strait of Hormuz, copper prices maintain a solid floor. This Monday, LME (London Metal Exchange) three-month copper reached $13,637 per tonne at one point, marking its highest level since January 29. On the same day, LME three-month copper recorded a peak closing price of $13,952/tonne, with intraday prices briefly rising above $14,500/tonne.

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

TradingKey - Cerebras Systems (CBRS) IPO prices May 13–14 at $125–$135/share. $26–$27B valuation, 20x oversubscribed, $510M revenue, 47% net margin, OpenAI 750MW deal. Everything you need to know.

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

TradingKey - The U.S. Bureau of Labor Statistics will release the April CPI report on May 12 at 8:30 a.m. ET. Since the outbreak of the U.S.-Iran conflict in late February, the global energy market has experienced the most severe geopolitical supply shock in history. As the conflict enters its third month, traffic through the Strait of Hormuz remains significantly below pre-war levels, with approximately 20% of the world's oil transit routes still facing "interruption." This inflation report will serve as a critical validation window for the transmission effects of oil prices.

'Big Short' Burry Doubles Down: Nvidia, Palantir Short Positions Double in Big Bet on AI Bubble Bursting

TradingKey — As the Nasdaq continues to hit consecutive record highs, Michael Burry—who rose to fame during the 2008 subprime mortgage crisis and was the inspiration for the film *The Big Short*—is betting with unprecedented intensity on the bursting of the AI bubble.

Featured Tools